VetCentric, a US-based provider of pet medication deliveries, has raised $3m as part of a continued round of series B funding, with Switzerland-based chocolate company Nestlé investing $1m. VetCentric said Nestlé Venture Capital Fund, the corporate venturing division of the Swiss company run by independent manager Inventages, and venture capital firms Sherbrooke Capital and Asset…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
